USE OF PREGNANCY SPECIFIC GLYCOPROTEIN FOR MATURATION OF OOCYTES
The use of PSG for the in vitro maturation of mammalian oocytes is described. The in vitro matured oocytes may be used for in vitro fertilization protocols.
1 . A method of maturing an oocyte in vitro comprising:
(a) providing an immature oocyte; and
(b) contracting the oocyte with pregnancy specific glycoprotein.
2 . The method of claim 1 wherein the pregnancy specific glycoprotein is selected from the group consisting of PSG1, PSG2, PSG3, PSG4, PSG5, PSG6, PSG7, PSG8, PSG9, PSG10 and PSG11.
3 . The method of claim 2 wherein the pregnancy specific glycoprotein is PSG5 or a polypeptide at least 80% identical thereto.
4 . The method of claim 1 wherein the immature oocyte is derived from a female that has not undergone external hormonal therapy.
5 . The method of claim 1 wherein the immature oocyte is derived from a female that has undergone external hormonal therapy.
6 . The method of claim 5 wherein the female was administered a hormone selected from the group consisting of GnRH, FSH, LH, hCG, and a combination thereof.
7 . The method of claim 1 wherein the immature oocyte is provided in a culture medium comprising a factor selected from the group consisting of FSH, hCG, estrachol, cysteamine, sodium pyruvate, glutamine, autologous heat-inactivated serum, and follicular fluid.
8 . A mature oocyte produced by the method of claim 1 .
9 . A method of producing an embryo in vitro comprising treating a mature oocyte with sperm, wherein said oocyte is produced by the method of claim 1 .
10 . A method of in vitro fertilization comprising implanting an embryo in need thereof, wherein said embryo is produced by a method comprising treating a mature oocyte with sperm, wherein said oocyte is produced by the method of claim 1.